What changed at closing

Accuray announced on November 13 that it completed its financing transaction with TCW, its primary lender and largest shareholder. TCW exchanged $40 million principal of a term loan for convertible preferred stock.

TCW’s $15 million cash investment, made when agreements were signed in July, has now also been exchanged for convertible preferred shares.

Waiver and additional liquidity

Certain financial covenants are waived through December 31, 2027, with the first test date on March 31, 2028. A delayed-draw term loan of up to $5 million is available subject to conditions; availability is not confirmation it has been drawn.

Shareholders approved the transaction proposals on October 6. A separate 1-for-40 reverse stock split took effect November 9. Those steps precede this closing, which does not establish that Accuray is debt-free or guarantee future growth.